Wikborg Rein & Co is a large general service law firm with Norwegian offices in Oslo and Bergen. The firm is very strong in patent litigation and consolidates its tier 1 ranking. Partners Gunnar Meyer and Ingvild Hanssen-Bauer are respected practitioners in the market and the firm acts for Teva/Ratiopharm and Actavis, the two biggest generic players in the Norwegian market. "I use it for patent litigation and it is very skilled in pharma with good knowledge of matters," one client says. "The best individuals are Gunnar Meyer and Ingvild Hanssen-Bauer. Gunnar [Meyer] never gives up and this is not only a strength but also a weakness."
Meyer and Hanssen-Bauer advised Pharmaq in the first Norwegian patent litigation matter in the field of living biological material. In fact, it was Scandinavia's first patent litigation related to living biological material. The matter relates to a patent on fish pancreatic disease and in May 2012, an appeal to the Supreme Court was dismissed. "Wikborg Rein has a couple of people that are very clever and Gunnar Meyer is one of them," one partner says.